HNN3.0

Project cooperationUpdated on 19 January 2026

Clinical Laboratory for Respiratory Pathogen Diagnostics and Validation

Professor at AZ Board of Regents on behalf of Arizona State University

Tempe, United States

About

Clinical Laboratory for Respiratory Pathogen Diagnostics and Validation

The Clinical Laboratory for Respiratory Pathogen Diagnostics and Validation is dedicated to advancing accurate, timely, and clinically meaningful diagnostic tools for respiratory infectious diseases. The laboratory focuses on the discovery, development, analytical assessment, and clinical validation of novel diagnostic assays across a broad range of respiratory pathogens, including emerging and re-emerging threats.

By leveraging well-characterized clinical specimens and real-world patient populations, the laboratory evaluates diagnostic performance, clinical accuracy, and utility in diverse care settings. Its work bridges basic innovation and clinical implementation, supporting transnational research, regulatory pathways, and evidence generation for adoption in clinical and public health practice.

The laboratory collaborates with academic, clinical, industry, and public health partners to accelerate diagnostic innovation, strengthen preparedness for outbreaks and pandemics, and improve patient outcomes through reliable, high-quality respiratory diagnostics.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Organisation

Similar opportunities

  • Project cooperation

    Integrated Omics–Driven Diagnostic Innovation Laboratory

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Vel Murugan

    Professor at AZ Board of Regents on behalf of Arizona State University

    Tempe, United States

  • Project cooperation

    NGS-based molecular diagnostics for lymphoproliferative diseases in Horizon Europe projects

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Silvia Angeletti

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    Clinical microbiology and advanced diagnostics for infectious diseases and antimicrobial resistance in Horizon Europe projects

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Silvia Angeletti

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy